Wolff Financial Management LLC Bristol Myers Squibb CO Transaction History

Wolff Financial Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	BUY	$57.89 - $64.73 $576,005 - $644,063	9,950 New	9,950 $577,000
Q2 2022 Aug 05, 2022	BUY	$72.62 - $79.98 $145,966 - $160,759	2,010 Added 25.31%	9,950 $766,000
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $425,822 - $496,408	7,940 New	7,940 $495,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $469,809 - $550,321	-7,940 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $6,171 - $6,940	-104 Reduced 1.29%	7,940 $501,000
Q4 2019 Jan 23, 2020	BUY	$49.21 - $64.19 $5,117 - $6,675	104 Added 1.31%	8,044 $516,000
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $387,154 - $502,046	7,940 New	7,940 $413,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Wolff Financial Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolff Financial Management LLC with notifications on news.